Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)

Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)

The objective of this survey was to understand the safety and efficacy of PAXIL tablets ("PAXIL", hereinafter) when it was started at 20 mg/day in subjects with depression or in a depressed state.

Inclusion Criteria:

• Patients with depression or in a depressed state
• Patients who start taking paroxetine at 20mg a day

Exclusion Criteria:

• Patients who have been treated with paroxetine prior to this investigation
• Patients with hypersensitivity to paroxetine
• Patients taking monoamine oxidase inhibitors (MAOIs) or within 2 weeks of stopping treatment with MAOIs
• Concomitant use in patients taking pimozide